The bystander result also explains, in part, why Enhertu is powerful towards tumors that have barely any HER2: once the ADC enters a tumor along with the drug molecules detach, they could eliminate neighboring tumor cells even if those bystanders don’t carry Substantially HER2 on their own surface. This action, along with the use of a diagnostic